Maravai LifeSciences Holdings Inc. (MRVI) NASDAQ
$7.37 0.07 (0.96%)
Market Cap: $975.09M
As of 04/22/24 04:00 PM EDT. Market closed.
Maravai LifeSciences Holdings Inc. (MRVI)
NASDAQ
$7.37
0.07 (0.96%)
Market Cap: $975.09M
As of 04/22/24 04:00 PM EDT. Market closed.
Add to Portfolio
maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Carl W. Hull
Full Time Employees
125
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Carl W. Hull
Full Time Employees
125
URL
Address
10770 Wateridge Circle, Suite 200, CA, San Diego, 92121.
PRICE CHART FOR MARAVAI LIFESCIENCES HOLDINGS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$7.41
Previous Close
$7.30
Days Range
$7.26 - $7.50
52 week range
$4.52 - $16.62
Volume
1,452,677
Avg. Volume (30 days)
2,117,172
Market Cap
$975.09M
Dividend Yield
-
P/E
(8.19)
Shares Outstanding
132,305,845
Open
$7.41
Previous Close
$7.30
Days Range
$7.26 - $7.50
52 week range
$4.52 - $16.62
Volume
1,452,677
Avg. Volume (30 days)
2,117,172
Market Cap
$975.09M
Dividend Yield
-
P/E
(8.19)
Shares Outstanding
132,305,845
FINANCIAL STATEMENTS FOR MARAVAI LIFESCIENCES HOLDINGS INC
LOADING...
INSIDER TRANSACTIONS FOR MARAVAI LIFESCIENCES HOLDINGS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
BURCH ANDREW | See Remarks | Apr 15, 2024 | Option Exercise | $8.11 | 16,758 | 135,907 | 420,035 | Apr 16, 2024, 06:01 PM |
BUZZEO REBECCA | See Remarks | Mar 15, 2024 | Option Exercise | $7.70 | 4,366 | 33,618 | 365,066 | Mar 18, 2024, 06:00 PM |
ORESHACK KURT | General Counsel | Mar 15, 2024 | Option Exercise | $7.70 | 4,551 | 35,043 | 223,349 | Mar 18, 2024, 05:59 PM |
Dolan Christine | See Remarks | Mar 15, 2024 | Option Exercise | $7.70 | 5,383 | 41,449 | 258,007 | Mar 18, 2024, 05:58 PM |
Leddy Peter Michael | See Remarks | Mar 15, 2024 | Option Exercise | $7.70 | 6,714 | 51,698 | 376,359 | Mar 18, 2024, 05:56 PM |
Herde Kevin | Chief Financial Officer | Mar 15, 2024 | Option Exercise | $7.70 | 8,624 | 66,405 | 332,914 | Mar 18, 2024, 05:55 PM |
HULL CARL | See Remarks | Mar 15, 2024 | Option Exercise | $7.70 | 17,560 | 135,212 | 267,072 | Mar 18, 2024, 05:54 PM |
ORESHACK KURT | General Counsel | Feb 15, 2024 | Option Exercise | $5.48 | 2,322 | 12,725 | 227,900 | Feb 20, 2024, 06:47 PM |
Herde Kevin | Chief Financial Officer | Feb 15, 2024 | Option Exercise | $5.48 | 2,664 | 14,599 | 341,538 | Feb 20, 2024, 06:47 PM |
Dolan Christine | See Remarks | Feb 15, 2024 | Option Exercise | $5.48 | 1,941 | 10,637 | 263,390 | Feb 20, 2024, 06:46 PM |
HULL CARL | See Remarks | Feb 15, 2024 | Option Exercise | $5.48 | 10,729 | 58,795 | 284,632 | Feb 20, 2024, 06:46 PM |
Leddy Peter Michael | See Remarks | Oct 31, 2023 | Option Exercise | $5.83 | 449 | 2,618 | 132,796 | Nov 16, 2023, 05:22 PM |
Herde Kevin | Chief Financial Officer | Oct 31, 2023 | Option Exercise | $5.83 | 1,861 | 10,850 | 93,925 | Nov 16, 2023, 05:22 PM |
Dolan Christine | See Remarks | Oct 31, 2023 | Option Exercise | $5.83 | 1,729 | 10,080 | 75,727 | Nov 16, 2023, 05:21 PM |
BUZZEO REBECCA | See Remarks | Nov 15, 2023 | Option Exercise | $5.19 | 4,549 | 23,609 | 81,234 | Nov 16, 2023, 05:21 PM |
MARTIN WILLIAM E. III | Chief Executive Officer | Oct 16, 2023 | Option Exercise | $7.54 | 66,197 | 499,125 | 281,858 | Oct 17, 2023, 05:12 PM |
Herde Kevin | Chief Financial Officer | Apr 28, 2023 | Option Exercise | $11.72 | 874 | 10,243 | 92,064 | Jul 19, 2023, 04:51 PM |
ORESHACK KURT | General Counsel | Apr 28, 2023 | Option Exercise | $11.72 | 1,014 | 11,884 | 63,370 | Jul 19, 2023, 04:51 PM |
Dolan Christine | See Remarks | Apr 28, 2023 | Option Exercise | $11.72 | 1,394 | 16,338 | 73,998 | Jul 19, 2023, 04:51 PM |
Leddy Peter Michael | See Remarks | Apr 28, 2023 | Option Exercise | $11.72 | 1,920 | 22,502 | 137,925 | Jul 19, 2023, 04:50 PM |
Leddy Peter Michael | See Remarks | Jul 17, 2023 | Option Exercise | $12.52 | 5,578 | 69,837 | 132,347 | Jul 19, 2023, 04:50 PM |
Dolan Christine | See Remarks | Feb 15, 2023 | Option Exercise | $15.23 | 1,956 | 29,790 | 16,829 | Feb 17, 2023, 04:34 PM |
NEEL BRIAN | See Remarks | Feb 15, 2023 | Option Exercise | $15.23 | 2,312 | 35,212 | 16,473 | Feb 17, 2023, 04:34 PM |
HULL CARL | Chief Executive Officer | Feb 15, 2023 | Option Exercise | $15.23 | 9,719 | 148,020 | 71,881 | Feb 17, 2023, 04:33 PM |
Herde Kevin | Chief Financial Officer | Feb 15, 2023 | Option Exercise | $15.23 | 2,611 | 39,766 | 18,683 | Feb 17, 2023, 04:32 PM |
ORESHACK KURT | General Counsel | Feb 15, 2023 | Option Exercise | $15.23 | 2,312 | 35,212 | 23,970 | Feb 17, 2023, 04:32 PM |
NEEL BRIAN | See Remarks | Oct 31, 2022 | Option Exercise | $14.11 | 329 | 4,642 | 18,785 | Nov 09, 2022, 05:39 PM |
Herde Kevin | Chief Financial Officer | Oct 31, 2022 | Option Exercise | $14.11 | 478 | 6,745 | 21,294 | Nov 09, 2022, 05:35 PM |
ORESHACK KURT | General Counsel | Oct 31, 2022 | Option Exercise | $14.11 | 351 | 4,953 | 26,282 | Nov 09, 2022, 05:35 PM |
ORESHACK KURT | General Counsel | Apr 29, 2022 | Option Exercise | $22.95 | 394 | 9,042 | 25,931 | Jun 27, 2022, 07:55 PM |
NEEL BRIAN | See Remarks | Apr 29, 2022 | Option Exercise | $22.95 | 572 | 13,127 | 18,456 | Jun 27, 2022, 07:55 PM |
Herde Kevin | Chief Financial Officer | Apr 29, 2022 | Option Exercise | $22.95 | 427 | 9,800 | 20,816 | Jun 27, 2022, 07:55 PM |
ORESHACK KURT | General Counsel | Apr 29, 2022 | Option Exercise | $22.95 | 394 | 9,042 | 25,931 | Jun 27, 2022, 06:43 PM |
Dolan Christine | See Remarks | Apr 29, 2022 | Option Exercise | $22.95 | 666 | 15,285 | 18,785 | Jun 27, 2022, 06:42 PM |
Herde Kevin | Chief Financial Officer | Apr 29, 2022 | Option Exercise | $22.95 | 427 | 9,800 | 20,816 | Jun 27, 2022, 06:42 PM |
NEEL BRIAN | See Remarks | Apr 29, 2022 | Option Exercise | $22.95 | 572 | 13,127 | 18,456 | Jun 27, 2022, 06:42 PM |
Herde Kevin | Chief Financial Officer | Oct 31, 2021 | Option Exercise | $22.95 | 392 | 8,996 | 889 | Jan 27, 2022, 04:00 PM |
Herde Kevin | Chief Financial Officer | Apr 30, 2021 | Option Exercise | $22.95 | 497 | 11,406 | 497 | Jan 27, 2022, 04:00 PM |
NEEL BRIAN | See Remarks | Oct 31, 2021 | Option Exercise | $22.95 | 598 | 13,724 | 884 | Jan 27, 2022, 04:00 PM |
NEEL BRIAN | See Remarks | Apr 30, 2021 | Option Exercise | $22.95 | 286 | 6,564 | 286 | Jan 27, 2022, 04:00 PM |
ORESHACK KURT | General Counsel | Apr 30, 2021 | Option Exercise | $22.95 | 495 | 11,360 | 7,995 | Jan 27, 2022, 04:00 PM |
ORESHACK KURT | General Counsel | Oct 31, 2021 | Option Exercise | $22.95 | 542 | 12,439 | 8,537 | Jan 27, 2022, 04:00 PM |
Dolan Christine | See Remarks | Oct 31, 2021 | Option Exercise | $22.95 | 203 | 4,659 | 1,119 | Jan 27, 2022, 04:00 PM |
Dolan Christine | See Remarks | Apr 30, 2021 | Option Exercise | $22.95 | 916 | 21,022 | 916 | Jan 27, 2022, 04:00 PM |
GTCR INVESTMENT XI LLC | Director | Sep 09, 2021 | Option Exercise | $50.00 | 2,931,441 | 146,572,050 | 21,681,033 | Sep 13, 2021, 04:21 PM |
GTCR INVESTMENT XI LLC | Director | Apr 08, 2021 | Option Exercise | $31.25 | 395,744 | 12,367,000 | 24,612,474 | Apr 09, 2021, 05:00 PM |
GTCR INVESTMENT XI LLC | Director | Apr 07, 2021 | Option Exercise | $31.25 | 2,638,297 | 82,446,781 | 25,008,218 | Apr 09, 2021, 05:00 PM |
HULL CARL | Chief Executive Officer | Nov 25, 2020 | Buy | $26.94 | 35,000 | 942,900 | 35,000 | Nov 30, 2020, 04:34 PM |
GTCR INVESTMENT XI LLC | Director | Nov 24, 2020 | Option Exercise | $25.51 | 1,319,148 | 33,658,060 | 27,646,515 | Nov 27, 2020, 04:43 PM |
GRAY SUSANNAH | Director | Nov 24, 2020 | Buy | $27.00 | 20,000 | 540,000 | 31,852 | Nov 25, 2020, 07:58 PM |
SELLERS LISA | See Remarks | Nov 24, 2020 | Buy | $27.00 | 18,888 | 509,976 | 18,888 | Nov 25, 2020, 07:54 PM |
Hance Robert B | Director | Nov 24, 2020 | Buy | $27.00 | 10,000 | 270,000 | 21,852 | Nov 25, 2020, 07:54 PM |
PRAHALAD MURALI | Director | Nov 24, 2020 | Buy | $27.00 | 18,000 | 486,000 | 29,852 | Nov 25, 2020, 07:53 PM |
LUCIER GREGORY T | Director | Nov 24, 2020 | Buy | $27.00 | 15,000 | 405,000 | 26,852 | Nov 25, 2020, 07:52 PM |
Hopfield Jessica | Director | Nov 24, 2020 | Buy | $27.00 | 50,000 | 1,350,000 | 61,852 | Nov 25, 2020, 07:52 PM |
ORESHACK KURT | General Counsel | Nov 24, 2020 | Buy | $27.00 | 7,500 | 202,500 | 7,500 | Nov 25, 2020, 07:52 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
BURCH ANDREW | See Remarks | 04/15/2024 | 135,907 |
BUZZEO REBECCA | See Remarks | 03/15/2024 | 33,618 |
ORESHACK KURT | General Counsel | 03/15/2024 | 35,043 |
Dolan Christine | See Remarks | 03/15/2024 | 41,449 |
Leddy Peter Michael | See Remarks | 03/15/2024 | 51,698 |
Herde Kevin | Chief Financial Officer | 03/15/2024 | 66,405 |
HULL CARL | See Remarks | 03/15/2024 | 135,212 |
ORESHACK KURT | General Counsel | 02/15/2024 | 12,725 |
Herde Kevin | Chief Financial Officer | 02/15/2024 | 14,599 |
Dolan Christine | See Remarks | 02/15/2024 | 10,637 |
HULL CARL | See Remarks | 02/15/2024 | 58,795 |
Leddy Peter Michael | See Remarks | 10/31/2023 | 2,618 |
Herde Kevin | Chief Financial Officer | 10/31/2023 | 10,850 |
Dolan Christine | See Remarks | 10/31/2023 | 10,080 |
BUZZEO REBECCA | See Remarks | 11/15/2023 | 23,609 |
MARTIN WILLIAM E. III | Chief Executive Officer | 10/16/2023 | 499,125 |
Herde Kevin | Chief Financial Officer | 04/28/2023 | 10,243 |
ORESHACK KURT | General Counsel | 04/28/2023 | 11,884 |
Dolan Christine | See Remarks | 04/28/2023 | 16,338 |
Leddy Peter Michael | See Remarks | 04/28/2023 | 22,502 |
Leddy Peter Michael | See Remarks | 07/17/2023 | 69,837 |
Dolan Christine | See Remarks | 02/15/2023 | 29,790 |
NEEL BRIAN | See Remarks | 02/15/2023 | 35,212 |
HULL CARL | Chief Executive Officer | 02/15/2023 | 148,020 |
Herde Kevin | Chief Financial Officer | 02/15/2023 | 39,766 |
ORESHACK KURT | General Counsel | 02/15/2023 | 35,212 |
NEEL BRIAN | See Remarks | 10/31/2022 | 4,642 |
Herde Kevin | Chief Financial Officer | 10/31/2022 | 6,745 |
ORESHACK KURT | General Counsel | 10/31/2022 | 4,953 |
ORESHACK KURT | General Counsel | 04/29/2022 | 9,042 |
NEEL BRIAN | See Remarks | 04/29/2022 | 13,127 |
Herde Kevin | Chief Financial Officer | 04/29/2022 | 9,800 |
ORESHACK KURT | General Counsel | 04/29/2022 | 9,042 |
Dolan Christine | See Remarks | 04/29/2022 | 15,285 |
Herde Kevin | Chief Financial Officer | 04/29/2022 | 9,800 |
NEEL BRIAN | See Remarks | 04/29/2022 | 13,127 |
Herde Kevin | Chief Financial Officer | 10/31/2021 | 8,996 |
Herde Kevin | Chief Financial Officer | 04/30/2021 | 11,406 |
NEEL BRIAN | See Remarks | 10/31/2021 | 13,724 |
NEEL BRIAN | See Remarks | 04/30/2021 | 6,564 |
ORESHACK KURT | General Counsel | 04/30/2021 | 11,360 |
ORESHACK KURT | General Counsel | 10/31/2021 | 12,439 |
Dolan Christine | See Remarks | 10/31/2021 | 4,659 |
Dolan Christine | See Remarks | 04/30/2021 | 21,022 |
GTCR INVESTMENT XI LLC | Director | 09/09/2021 | 146,572,050 |
GTCR INVESTMENT XI LLC | Director | 04/08/2021 | 12,367,000 |
GTCR INVESTMENT XI LLC | Director | 04/07/2021 | 82,446,781 |
HULL CARL | Chief Executive Officer | 11/25/2020 | 942,900 |
GTCR INVESTMENT XI LLC | Director | 11/24/2020 | 33,658,060 |
GRAY SUSANNAH | Director | 11/24/2020 | 540,000 |
SELLERS LISA | See Remarks | 11/24/2020 | 509,976 |
Hance Robert B | Director | 11/24/2020 | 270,000 |
PRAHALAD MURALI | Director | 11/24/2020 | 486,000 |
LUCIER GREGORY T | Director | 11/24/2020 | 405,000 |
Hopfield Jessica | Director | 11/24/2020 | 1,350,000 |
ORESHACK KURT | General Counsel | 11/24/2020 | 202,500 |
Load More Insider Transactions
FUNDS WITH A POSITION IN MARAVAI LIFESCIENCES HOLDINGS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
12 WEST CAPITAL MANAGEMENT LP | 11,602,988 | 6.76% | 79.53% | Growth |
BLACKROCK INC. | 6,481,668 | 0.00108% | 9.35% | Other |
AQR CAPITAL MANAGEMENT LLC | 3,504,111 | 0.04% | 100.35% | Other |
RENAISSANCE TECHNOLOGIES LLC | 2,885,689 | 0.03% | 8.5% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,768,011 | 0.00121% | 3.7% | Other |
BAMCO INC /NY/ | 1,483,651 | 0.03% | 117.81% | Growth At A Reasonable Price |
D. E. SHAW & CO., INC. | 1,232,499 | 0.00705% | 60.22% | Other |
GOTHAM ASSET MANAGEMENT, LLC | 524,913 | 0.06% | 0.17% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 495,426 | 0.00609% | -14.21% | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR MARAVAI LIFESCIENCES HOLDINGS INC
STOCK BUYBACKS FOR MARAVAI LIFESCIENCES HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.16%
1Q
06/30/2023
0.21%
2Q
03/31/2023
0.31%
3Q
12/31/2022
-48.25%
4Q
09/30/2022
0.37%
5Q
06/30/2022
-48.25%
6Q
03/31/2022
-48.24%
7Q
12/31/2021
-48.75%
8Q
09/30/2021
-48.79%
9Q
06/30/2021
17.69%
10Q
03/31/2021
36.69%
11Q
09/30/2020
-47.96%
13Q
06/30/2020
-47.96%
14Q
03/31/2020
-47.96%
15Q
12/31/2019
-47.96%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MARAVAI LIFESCIENCES HOLDINGS INC
LOADING...